SlideShare una empresa de Scribd logo
1 de 112
Neoplasia 4 Fe A. Bartolome, MD, FPASMAP Department of Pathology Our Lady of Fatima University
Chemical  Carcinogenesis
Chemical  Carcinogenesis ,[object Object]
Initiation alone is not sufficient for tumor formation.
Initiation causes permanent DNA damage (mutations). It is rapid and irreversible  and has  “memory.”,[object Object]
For the change to be heritable, the damaged DNA template must be replicated
For initiation to occur, altered cells must undergo at least one cycle of proliferation so that DNA change becomes fixed,[object Object]
Tumors do not result when the promoting agent is applied before, rather than after, the initiating agent.
The cellular changes resulting from application of promoters do not affect DNA directly and are reversible.,[object Object]
Mutated cells with reduced growth factor requirements
Process of tumor promotion includes multiple steps: proliferation of pre-neoplastic cells, malignant conversion, and tumor progression,[object Object]
Chemical Carcinogenesis: Initiators Direct-Acting Agents ,[object Object]
Most are weak carcinogens; some are chemotherapeutic drugs (e.g. Alkylating drugs)
Risk of induced cancer is low.,[object Object]
Chemical Carcinogenesis: Initiators Indirect-Acting Agents ,[object Object]
Polycyclic hydrocarbons
present in fossil fuels; animal fats during process of broiling meats; smoked meat and fish
Principal active product: epoxides form adducts with DNA, RNA, and proteins,[object Object]
Example: benzo[a]pyrene light smokers with the susceptible genotype CYP1A1 with 7x higher risk of developing lung cancer,[object Object]
Any gene may be the target  commonly mutated are RAS and p53
Aflatoxin B1  cause G:C  T:A transversion in codon 249 of p53,[object Object]
Degree of risk depends on:Type of UV ray Intensity of exposure Quantity of light-absorbing protective coat of melanin
UVB radiation is the main cause of sunburn and skin cancer although mounting evidence suggests UVA may also play a role. UVB does not penetrate the skin as deeply as UVA but has more energy and therefore does more damage to the skin.
UVB sunlight is directly absorbed by DNA resulting in single strand breaks and the formation of pyrimidinedimers.
Radiation Carcinogenesis Ionizing Radiation ,[object Object]
Lead to formation of reactive oxygen species or free radicals,[object Object]
Intermediate: breast, lungs, salivary glands
Resistant: skin, bone, GIT,[object Object]
Microbial Carcinogenesis
Microbial Carcinogenesis
Microbial Carcinogenesis Oncogenic RNA Viruses: HTLV type 1 ,[object Object]
Does not contain an oncogene
Viral integration shows clonal pattern  site of integration identical within all cells of a given cancer,[object Object]
Genes encoding IL-2 & its receptor
Gene for myeloid growth factor granulocyte-macrophage colony-stimulating factor,[object Object]
Microbial Carcinogenesis OncogenicDNAViruses: HPV ,[object Object]
HPV genome integrated into host genome  site of integration random but pattern of integration is clonal,[object Object]
Microbial Carcinogenesis OncogenicDNAViruses: HPV ,[object Object],[object Object]
Microbial Carcinogenesis OncogenicDNAViruses: EBV ,[object Object]
Infects B cells and possibly epithelial cells of the oropharynx via complement receptor CD21,[object Object]
Involves the “hijacking” of several normal signalling pathways,[object Object]
Microbial Carcinogenesis OncogenicDNAViruses: EBV ,[object Object],Encodes a nuclear protein that mimics a constitutively active Notch receptor Transactivates several host genes  cyclin D and src family of proto-oncogenes
Microbial Carcinogenesis OncogenicDNAViruses: EBV ,[object Object]
Impair immune competence  allow sustained B-cell proliferation
Cause translocations that activate c-MYC oncogene,[object Object]
No consistent pattern of integration in liver cells
Immunologically-mediated chronic inflammation with hepatocyte death  regeneration and genomic damage,[object Object]
Microbial Carcinogenesis Helicobacter pylori ,[object Object]
Implicated in gastric adenocarcinoma and gastric lymphomas
Involves increased epithelial cell proliferation in a background of chronic inflammation  contain genotoxic agents such as ROS,[object Object]
Penetrates into gastric epithelial cells  initiate signalling cascade that mimics unregulated growth factor stimulation
Additional mutations may be acquired (e.g. (11:18) translocation)  cause constitutive activation of NF-κβ,[object Object]
Tumor Immunity Immune surveillance ,[object Object]
(+) lymphocytic infiltrates around tumors and in LN draining sites of cancer
Increased incidence of cancer in immunocompromised individuals
Demonstration of tumor-specific T cells and antibodies,[object Object]
Initially classified as:Tumor-specific antigens ,[object Object],Tumor-associated antigens ,[object Object],[object Object]
Not present in normal cells  do not induce self-tolerance,[object Object],[object Object],[object Object]
Genes silenced during development and activated during malignant transformation,[object Object]
Tumor Immunity Tumor antigens Altered cell surface glycolipids and glycoproteins ,[object Object]
Melanomas: high levels of gangliosides GM2, GD2, and GD3
Target for cancer therapy with specific antibodies,[object Object]
Cancer cells entering the bloodstream form complex thromboemboli with platelets and leukocytes, which are thought to facilitate arrest at ectopic sites, assist interactions with the endothelium, and help in evasion of the immune system. Current data suggest that this phenomenon can be explained by interactions between platelet and/or endothelial P-selectin and carcinoma mucins.
Tumor Immunity Tumor antigens Cell type-specific differentiation antigens ,[object Object]
Typically normal self-antigens  do not induce immune response
Potential targets for immunotherapy and for identifying the tissue of origin of tumors,[object Object]
Tumor Immunity Anti-tumorEffector Mechanisms Cytotoxic T lymphocytes ,[object Object]
Demonstrated in blood and tumor infiltrates of cancer patients,[object Object]
Tumor Immunity Anti-tumorEffector Mechanisms Natural killer cells ,[object Object]
Activated by IL-2 and IL-5; may be activated by tumors that fail to express MHC class I antigens
NKG2D proteins  activating receptors; recognize stress-induced antigens expressed on tumor cells,[object Object]
Tumor Immunity Anti-tumorEffector Mechanisms Macrophages  ,[object Object]
Kill tumors by mechanisms similar to those used to kill microbes or by secretion of TNF,[object Object]
Tumor Immunity Anti-tumorEffector Mechanisms Antibodies  ,[object Object]
Monoclonal antibody vs. CD20 (B-cell surface antigen)  treatment of lymphomas,[object Object],[object Object],[object Object]
Express arginase arginine essential component of TCR  loss of T cell recognition,[object Object]
Immune response induced by the tumor may inhibit tumor immunity by activation of T-cell inhibitory receptor CTLA4,[object Object],[object Object],[object Object],[object Object]
Clinical Aspects of Neoplasia ,[object Object],Location and impingement on adjacent structures Functional activity (e.g. Hormone synthesis or development of para-neoplastic syndrome) Bleeding and infections due to ulceration of tumor through adjacent surfaces Symptoms due to rupture or infarction Cachexia or wasting
Clinical Aspects of Neoplasia Local and Hormonal Effects ,[object Object]
Hormone production seen in neoplasms arising in endocrine glands  more typical of benign tumor
Neoplasms in the gut  obstruction or intussusception,[object Object]
Melena and hematuria characteristic of neoplasms of the gut and urinary tract,[object Object],[object Object]
Clinical Aspects of Neoplasia Paraneoplastic Syndromes Endocrinopathies ,[object Object]
Cushing syndrome – most common endocrinopathy 50% with small cell CA of lungs; due to excessive corticotropin production,[object Object]
Two processes involved:Osteolysis induced by cancer Production of calcemichumoral substances in extra-osseous neoplasms
Clinical Aspects of Neoplasia Paraneoplastic Syndromes Acanthosisnigricans ,[object Object]
Genetically determined; juveniles or adults,[object Object]
Clinical Aspects of Neoplasia Cancer Cachexia ,[object Object]
Weight loss results equally from loss of fat and lean muscle
Due to increased basal metabolic rate despite reduced food intake,[object Object]
Grading and Staging Cancer Grading ,[object Object]
Provides information about potential behavior of tumor
Of less clinical value than staging,[object Object]

Más contenido relacionado

La actualidad más candente

General pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsGeneral pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsviancksislove
 
Plasma cell disorders
Plasma cell disordersPlasma cell disorders
Plasma cell disordersVijay Shankar
 
Neoplasia Robbin's path
Neoplasia Robbin's pathNeoplasia Robbin's path
Neoplasia Robbin's pathPrasad CSBR
 
Cell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And AccumulationsCell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And AccumulationsMD Specialclass
 
Pathology neoplasm
Pathology  neoplasmPathology  neoplasm
Pathology neoplasmMBBS IMS MSU
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of CancerMohsin Shad
 
Epithelial tumor markers
Epithelial tumor markersEpithelial tumor markers
Epithelial tumor markersvarun surya
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerSubramani Parasuraman
 
Amyloidosis and pathological calcification
Amyloidosis and pathological calcificationAmyloidosis and pathological calcification
Amyloidosis and pathological calcificationDr Neha Mahajan
 
Paraneoplastic syndrome
Paraneoplastic syndromeParaneoplastic syndrome
Paraneoplastic syndromeariva zhagan
 
Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm           Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm Chhavi Singh
 
Cancer lab diagnosis
Cancer lab diagnosisCancer lab diagnosis
Cancer lab diagnosisimrana tanvir
 
Carcinoma - Lung
Carcinoma - LungCarcinoma - Lung
Carcinoma - LungPrasad CSBR
 

La actualidad más candente (20)

General pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsGeneral pathology lecture 7 neoplasms
General pathology lecture 7 neoplasms
 
Neoplasia 2
Neoplasia 2Neoplasia 2
Neoplasia 2
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Plasma cell disorders
Plasma cell disordersPlasma cell disorders
Plasma cell disorders
 
Granulomatous inflammation
Granulomatous inflammation Granulomatous inflammation
Granulomatous inflammation
 
Neoplasia Robbin's path
Neoplasia Robbin's pathNeoplasia Robbin's path
Neoplasia Robbin's path
 
Cell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And AccumulationsCell Injury, Adaptation And Accumulations
Cell Injury, Adaptation And Accumulations
 
Pathology neoplasm
Pathology  neoplasmPathology  neoplasm
Pathology neoplasm
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of Cancer
 
Epithelial tumor markers
Epithelial tumor markersEpithelial tumor markers
Epithelial tumor markers
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancer
 
Neoplasia 1 basic
Neoplasia 1 basicNeoplasia 1 basic
Neoplasia 1 basic
 
Amyloidosis and pathological calcification
Amyloidosis and pathological calcificationAmyloidosis and pathological calcification
Amyloidosis and pathological calcification
 
Paraneoplastic syndrome
Paraneoplastic syndromeParaneoplastic syndrome
Paraneoplastic syndrome
 
Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm           Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm
 
Hallmarks in cancer
Hallmarks in cancerHallmarks in cancer
Hallmarks in cancer
 
Neoplasia part 1
Neoplasia part 1Neoplasia part 1
Neoplasia part 1
 
Hereditary cancer
Hereditary cancerHereditary cancer
Hereditary cancer
 
Cancer lab diagnosis
Cancer lab diagnosisCancer lab diagnosis
Cancer lab diagnosis
 
Carcinoma - Lung
Carcinoma - LungCarcinoma - Lung
Carcinoma - Lung
 

Similar a Neoplasia 4

Similar a Neoplasia 4 (20)

Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Neoplasia class 5.ppt
Neoplasia class 5.pptNeoplasia class 5.ppt
Neoplasia class 5.ppt
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Carcinogenic agents and their cellular interaction
Carcinogenic agents and their cellular interactionCarcinogenic agents and their cellular interaction
Carcinogenic agents and their cellular interaction
 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
 
Oncogenisis and Tumor Markers
Oncogenisis and Tumor Markers Oncogenisis and Tumor Markers
Oncogenisis and Tumor Markers
 
16 CARCINOGENESIS.pptx
16 CARCINOGENESIS.pptx16 CARCINOGENESIS.pptx
16 CARCINOGENESIS.pptx
 
Cancer pathophysiology dietetics-1
Cancer pathophysiology dietetics-1Cancer pathophysiology dietetics-1
Cancer pathophysiology dietetics-1
 
Oncogenesis
OncogenesisOncogenesis
Oncogenesis
 
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
 
DNA Oncogenic Viruses
DNA Oncogenic VirusesDNA Oncogenic Viruses
DNA Oncogenic Viruses
 
Oncogenic virus-host cell interaction
Oncogenic virus-host cell interactionOncogenic virus-host cell interaction
Oncogenic virus-host cell interaction
 
Infection_ and neoplasia.pptx
Infection_ and neoplasia.pptxInfection_ and neoplasia.pptx
Infection_ and neoplasia.pptx
 
Tumor Immunology
Tumor ImmunologyTumor Immunology
Tumor Immunology
 
Tumour immunology leture notes
Tumour immunology leture notesTumour immunology leture notes
Tumour immunology leture notes
 
CANCER
CANCERCANCER
CANCER
 
Infections and cancer
Infections and cancerInfections and cancer
Infections and cancer
 
Oncogenesis AAR
Oncogenesis AAROncogenesis AAR
Oncogenesis AAR
 

Más de MD Specialclass

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...MD Specialclass
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionMD Specialclass
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headachesMD Specialclass
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL MD Specialclass
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL MD Specialclass
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinomaMD Specialclass
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disordersMD Specialclass
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitisMD Specialclass
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosisMD Specialclass
 

Más de MD Specialclass (20)

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutrition
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headaches
 
Acute brain attack 911
Acute brain attack  911Acute brain attack  911
Acute brain attack 911
 
Hema intro anemia
Hema intro anemiaHema intro anemia
Hema intro anemia
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
Fever & id diet final
Fever & id diet finalFever & id diet final
Fever & id diet final
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disorders
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Thyroid
ThyroidThyroid
Thyroid
 
Dermatology dr.n.ramos
Dermatology   dr.n.ramosDermatology   dr.n.ramos
Dermatology dr.n.ramos
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitis
 
Pancreatic disease
Pancreatic diseasePancreatic disease
Pancreatic disease
 
Liver disease
Liver diseaseLiver disease
Liver disease
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosis
 

Último

Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native ApplicationsWSO2
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Zilliz
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfOverkill Security
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Drew Madelung
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingEdi Saputra
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...apidays
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonAnna Loughnan Colquhoun
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?Igalia
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxRustici Software
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...Martijn de Jong
 
Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024The Digital Insurer
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoffsammart93
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusZilliz
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 

Último (20)

Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source Milvus
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 

Neoplasia 4